Jump to main content
Jump to site search

Issue 21, 2015
Previous Article Next Article

Affinity imaging mass spectrometry (AIMS): high-throughput screening for specific small molecule interactions with frozen tissue sections

Author affiliations

Abstract

A novel screening system, using affinity imaging mass spectrometry (AIMS), has been developed to identify protein aggregates or organ structures in unfixed human tissue. Frozen tissue sections are positioned on small (millimetre-scale) stainless steel chips and incubated with an extensive library of small molecules. Candidate molecules showing specific affinity for the tissue section are identified by imaging mass spectrometry (IMS). As an example application, we screened over a thousand compounds against Alzheimer's disease (AD) brain tissue and identified several compounds with high affinity for AD brain sections containing tau deposits compared to age-matched controls. It should also be possible to use AIMS to isolate chemical compounds with affinity for tissue structures or components that have been extensively modified by events such as oxidation, phosphorylation, acetylation, aggregation, racemization or truncation, for example, due to aging. It may also be applicable to biomarker screening programs.

Graphical abstract: Affinity imaging mass spectrometry (AIMS): high-throughput screening for specific small molecule interactions with frozen tissue sections

Back to tab navigation

Supplementary files

Article information


Submitted
09 Jul 2015
Accepted
27 Aug 2015
First published
27 Aug 2015

Analyst, 2015,140, 7202-7208
Article type
Paper
Author version available

Affinity imaging mass spectrometry (AIMS): high-throughput screening for specific small molecule interactions with frozen tissue sections

T. Yoshimi, S. Kawabata, S. Taira, A. Okuno, R. Mikawa, S. Murayama, K. Tanaka and O. Takikawa, Analyst, 2015, 140, 7202
DOI: 10.1039/C5AN01381J

Social activity

Search articles by author

Spotlight

Advertisements